Impact of COX- 2 “Cyclooxygenase 2” in Breast Cancer

COX-2 “Cyclooxygenase 2“as a Prognostic marker in Breast Cancer

IMMUNOHISTOCHEMICAL STUDY OF COX-2 EXPRESSION IN COLORECTAL CARCINOMA

Immunohistochemical Expression of Cyclin D1 in Breast Carcinoma

Expression of Cyclooxygenase 2 (COX-2) and Vascular Endothelial Growth Factor (VEGF) in Gastric Carcinoma and Relationship with Clinicopathological Parameters

Histopathological and Immunohistochemical Study of the Prognostic Significance of Cox2 and CDX2 Expression in the Available Cases of Colorectal Carcinoma

Expression of Tumor infiltrating Lymphocytes (Tils), Forkhead Box P3 (FOXP3) and Cyclooxygenase-2 (COX2) in Breast Cancer Patient’s Tumor Tissue, A Single Institute Study

Cyclo-oxygenase-2 and vascular endothelial growth factor expression in colorectal cancer patients

Immunoexpression of Ki-67 and Cyclooxygenase-2 in Odontogenic Keratocyst and Dentigerous Cyst: A Comparative Study

COMPARATIVE STUDY OF IMMUNOHISTOCHEMICAL EXPRESSION OF GP88 AND Cath-D AS PROGNOSTIC MARKERS AND CORRELATION WITH PATHOLOGICAL AND HISTOLOGICAL PARAMETERS IN HUMAN BREAST CANCER